Results 1 to 10 of about 1,172,080 (268)

Malignant Tumors of the Eye [PDF]

Ca-A Cancer Journal for Clinicians, 1969
Taylor R Smith
exaly   +3 more sources

Endothelial-to-mesenchymal transition in tumour progression and its potential roles in tumour therapy

Annals of Medicine, 2023
Tumour-associated endothelial cells (TECs) are a critical stromal cell type in the tumour microenvironment and play central roles in tumour angiogenesis.
Zeli Yin, Liming Wang
doaj   +1 more source

Novel insight into histological and molecular astrocytoma, IDH‐mutant, Grade 4 by the updated WHO classification of central nervous system tumors

Cancer Medicine, 2023
Background The latest fifth edition of the World Health Organization (WHO) classification of the central nervous system (CNS) tumors (WHO CNS 5 classification) released in 2021 defined astrocytoma, IDH‐mutant, Grade 4.
Wenlin Chen, Siying Guo, Yaning Wang, Yixin Shi, Xiaopeng Guo, Delin Liu, Yilin Li, Yuekun Wang, Hao Xing, Yu Xia, Junlin Li, Jiaming Wu, Tingyu Liang, Hai Wang, Qianshu Liu, Shanmu Jin, Tian Qu, Huanzhang Li, Tianrui Yang, Kun Zhang, Yu Wang, Wenbin Ma   +21 more
doaj   +1 more source

Heterogeneity of cancer-associated fibroblasts and roles in the progression, prognosis, and therapy of hepatocellular carcinoma

Journal of Hematology & Oncology, 2019
Hepatocellular carcinoma (HCC) is a lethal disease, and recurrence and metastasis are the major causes of death in HCC patients. Cancer-associated fibroblasts (CAFs), a major stromal cell type in the HCC microenvironment, promote HCC progression, and ...
Zeli Yin, Chengyong Dong, Keqiu Jiang, Zhe Xu, Rui Li, Kun Guo, Shujuan Shao, Liming Wang   +7 more
doaj   +1 more source

Plasma circulating cell‐free MYCN gene: A noninvasive and prominent recurrence monitoring indicator of neuroblastoma

Cancer Reports, 2023
The postoperative recurrence of neuroblastoma (NB) patients is an essential reason for the high mortality of NB due to the lack of early, non‐invasive, and dynamic strategies for monitoring NB recurrence.
Ying Liang, Yan Liu, Pin Zhang, Mengxin Zhang, Bang Du, Weyland Cheng, Zhidan Yu, Lifeng Li, Huanmin Wang, Guangjun Hou, Xianwei Zhang, Wancun Zhang   +11 more
doaj   +1 more source

Integrating scRNA and bulk-RNA sequencing develops a cell senescence signature for analyzing tumor heterogeneity in clear cell renal cell carcinoma

Frontiers in Immunology, 2023
IntroductionCellular senescence (CS) plays a critical role in cancer development, including clear cell renal cell carcinoma (ccRCC). Traditional RNA sequencing cannot detect precise molecular composition changes within tumors. This study aimed to analyze
Qiming Gong, Qiming Gong, Yan Jiang, Junfeng Xiong, Fahui Liu, Jikui Guan   +5 more
doaj   +1 more source

Prognostic Value of Choline and Other Metabolites Measured Using ¹H-Magnetic Resonance Spectroscopy in Gliomas: A Meta-Analysis and Systemic Review

Metabolites, 2022
Glioma is the most prevalent primary central nervous system malignant tumor, with high heterogeneity observed among different grades; therefore, non-invasive prediction of prognosis could improve the clinical management of patients with glioma.
Yixin Shi, Delin Liu, Ziren Kong, Qianshu Liu, Hao Xing, Yuekun Wang, Yu Wang, Wenbin Ma   +7 more
doaj   +1 more source

An online survival predictor in glioma patients using machine learning based on WHO CNS5 data

Frontiers in Neurology, 2023
BackgroundThe World Health Organization (WHO) CNS5 classification system highlights the significance of molecular biomarkers in providing meaningful prognostic and therapeutic information for gliomas.
Liguo Ye, Lingui Gu, Zhiyao Zheng, Zhiyao Zheng, Zhiyao Zheng, Xin Zhang, Hao Xing, Xiaopeng Guo, Xiaopeng Guo, Wenlin Chen, Yaning Wang, Yuekun Wang, Tingyu Liang, Hai Wang, Yilin Li, Yilin Li, Shanmu Jin, Shanmu Jin, Yixin Shi, Yixin Shi, Delin Liu, Delin Liu, Tianrui Yang, Tianrui Yang, Qianshu Liu, Qianshu Liu, Congcong Deng, Yu Wang, Yu Wang, Wenbin Ma, Wenbin Ma   +30 more
doaj   +1 more source

Characteristic analysis and identification of novel molecular biomarkers in elderly glioblastoma patients using the 2021 WHO Classification of Central Nervous System Tumors

Frontiers in Neuroscience, 2023
IntroductionElderly glioblastoma (GBM) patients is characterized by high incidence and poor prognosis. Currently, however, there is still a lack of adequate molecular characterization of elderly GBM patients.
Yaning Wang, Junlin Li, Junlin Li, Yaning Cao, Yaning Cao, Wenlin Chen, Hao Xing, Xiaopeng Guo, Xiaopeng Guo, Yixin Shi, Yixin Shi, Yuekun Wang, Tingyu Liang, Liguo Ye, Delin Liu, Delin Liu, Tianrui Yang, Tianrui Yang, Yu Wang, Yu Wang, Wenbin Ma, Wenbin Ma   +21 more
doaj   +1 more source

Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors

Frontiers in Neuroscience, 2023
IntroductionThe fifth edition of the World Health Organization (WHO) classification of central nervous system (CNS) tumors released in 2021 formally defines pediatric-type diffuse gliomas.
Wenlin Chen, Shanmu Jin, Shanmu Jin, Qianshu Liu, Qianshu Liu, Hai Wang, Yu Xia, Yu Xia, Xiaopeng Guo, Xiaopeng Guo, Siying Guo, Siying Guo, Yaning Wang, Yixin Shi, Yixin Shi, Delin Liu, Delin Liu, Yilin Li, Yilin Li, Yuekun Wang, Hao Xing, Junlin Li, Junlin Li, Jiaming Wu, Jiaming Wu, Tingyu Liang, Tian Qu, Tian Qu, Huanzhang Li, Huanzhang Li, Tianrui Yang, Tianrui Yang, Kun Zhang, Kun Zhang, Yu Wang, Yu Wang, Wenbin Ma, Wenbin Ma   +37 more
doaj   +1 more source